Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Go back to Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $4.76 
Open $2.16    52 Week Low $1.46 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $-1.91 
Volume 212,979